Indrayani Biotech Ltd
BSE:526445
Indrayani Biotech Ltd
BSE:526445
Price:
8.17
INR
1.62%
Market Closed
Market Cap:
₹372.1m
Income Statement
Earnings Waterfall
Indrayani Biotech Ltd
Indrayani Biotech Ltd
Income Statement
Indrayani Biotech Ltd
Indrayani Biotech Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
18
|
0
|
0
|
0
|
50
|
0
|
0
|
0
|
99
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
616
N/A
|
872
+42%
|
1 002
+15%
|
1 309
+31%
|
1 629
+24%
|
1 796
+10%
|
1 780
-1%
|
1 711
-4%
|
1 662
-3%
|
1 554
-6%
|
1 458
-6%
|
1 240
-15%
|
1 302
+5%
|
1 278
-2%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(414)
|
(572)
|
(656)
|
(826)
|
(1 022)
|
(1 142)
|
(1 113)
|
(1 090)
|
(1 038)
|
(866)
|
(769)
|
(626)
|
(883)
|
(886)
|
|
| Gross Profit |
202
N/A
|
300
+49%
|
346
+15%
|
483
+40%
|
607
+26%
|
654
+8%
|
667
+2%
|
621
-7%
|
624
+0%
|
689
+10%
|
689
+0%
|
614
-11%
|
420
-32%
|
392
-7%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(141)
|
(215)
|
(239)
|
(344)
|
(468)
|
(522)
|
(518)
|
(497)
|
(425)
|
(477)
|
(518)
|
(453)
|
(390)
|
(394)
|
|
| Selling, General & Administrative |
(126)
|
(146)
|
(139)
|
(180)
|
(235)
|
(245)
|
(246)
|
(228)
|
(311)
|
(243)
|
(243)
|
(227)
|
(288)
|
(169)
|
|
| Depreciation & Amortization |
(7)
|
(13)
|
(19)
|
(24)
|
(33)
|
(36)
|
(37)
|
(40)
|
(38)
|
(37)
|
(56)
|
(60)
|
(34)
|
(77)
|
|
| Other Operating Expenses |
(8)
|
(56)
|
(81)
|
(140)
|
(199)
|
(241)
|
(235)
|
(229)
|
(76)
|
(197)
|
(219)
|
(165)
|
(68)
|
(148)
|
|
| Operating Income |
61
N/A
|
85
+38%
|
107
+26%
|
139
+30%
|
139
0%
|
131
-5%
|
148
+13%
|
125
-16%
|
199
+59%
|
212
+7%
|
171
-19%
|
161
-6%
|
30
-81%
|
(2)
N/A
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(17)
|
(28)
|
(31)
|
(37)
|
(50)
|
(66)
|
(64)
|
(66)
|
(97)
|
(101)
|
(106)
|
(102)
|
(101)
|
(104)
|
|
| Non-Reccuring Items |
0
|
0
|
(3)
|
(5)
|
(5)
|
(5)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
6
|
25
|
24
|
39
|
41
|
22
|
22
|
8
|
13
|
15
|
14
|
13
|
41
|
|
| Pre-Tax Income |
45
N/A
|
63
+40%
|
98
+57%
|
121
+23%
|
123
+2%
|
101
-18%
|
104
+3%
|
81
-22%
|
110
+36%
|
123
+12%
|
80
-35%
|
73
-8%
|
(57)
N/A
|
(65)
-13%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
(4)
|
(6)
|
(6)
|
(6)
|
(7)
|
(4)
|
(3)
|
|
| Income from Continuing Operations |
45
|
63
|
98
|
121
|
119
|
98
|
100
|
77
|
104
|
117
|
73
|
66
|
(61)
|
(68)
|
|
| Net Income (Common) |
44
N/A
|
62
+40%
|
98
+58%
|
121
+23%
|
119
-1%
|
98
-18%
|
100
+3%
|
77
-23%
|
104
+36%
|
117
+12%
|
73
-37%
|
66
-10%
|
(61)
N/A
|
(68)
-11%
|
|
| EPS (Diluted) |
1.3
N/A
|
1.82
+40%
|
2.87
+58%
|
3.54
+23%
|
2.74
-23%
|
2.85
+4%
|
2.93
+3%
|
1.56
-47%
|
2.68
+72%
|
1.37
-49%
|
1.6
+17%
|
1.44
-10%
|
-1.34
N/A
|
-1.3
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
